The protective effect of intratympanic dexamethasone on cisplatin-induced ototoxicity in guinea pigs

Otolaryngology - Head and Neck Surgery

Volumn 137, Issue 5, 2007, Pages 747-752

  Daldal, Alper ^a   Odabasi, Onur ^b   Serbetcioglu, Bulent ^c  

^a Acipayam Goverment Hospital   (Turkey)

^b ADNAN MENDERES UNIVERSITY   (Turkey)

^c DOKUZ EYLUL UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; DEXAMETHASONE; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTINUOUS INFUSION; DISTORTION PRODUCT OTOACOUSTIC EMISSION; DRUG EFFICACY; EAR PROTECTION; FEMALE; GUINEA PIG; HAIR CELL; NONHUMAN; OTOTOXICITY; SIGNAL NOISE RATIO; TREATMENT RESPONSE;

ANIMALS; ANTINEOPLASTIC AGENTS; CISPLATIN; DEXAMETHASONE; FEMALE; GLUCOCORTICOIDS; GUINEA PIGS; HAIR CELLS, AUDITORY; HEARING LOSS, BILATERAL; INJECTIONS; OTOACOUSTIC EMISSIONS, SPONTANEOUS; TYMPANIC MEMBRANE;

EID: 35448949111     PISSN: 01945998     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.otohns.2007.05.068     Document Type: Article

References (21)

1. Sakamoto M., Kaga K., and Kamio T. Extended high-frequency ototoxicity induced by the first administration of cisplatin. Otolaryngol Head Neck Surg 122 (2000) 828-833
2. Cooley M.E., Davis L., and Abrahm J. Cisplatin: a clinical review. Part II-Nursing assessment and management of side effects of cisplatin. Cancer Nurs 17 (1994) 283-293
3. Laurell G., and Bagger-Sjoback D. Dose-dependent inner ear changes after i.v. administration of cisplatin. J Otolaryngol 20 (1991) 158-167
4. Watanabe K., Hess A., Michel O., et al. Nitric oxide synthase inhibitor reduces the apoptotic change in the cisplatin-treated cochlea of guinea pigs. Anticancer Drugs 11 (2000) 731-735
5. Takumida M., and Anniko M. Nitric oxide in guinea pig vestibular sensory cells following gentamicin exposure in vitro. Acta Otolaryngol 121 (2001) 346-350
6. Wimmer C., Mees K., Stumpf P., et al. Round window application of D-methionine, sodium thiosulfate, brain-derived neurotrophic factor, and fibroblast growth factor-2 in cisplatin-induced ototoxicity. Otol Neurotol 25 (2004) 33-40
7. Rybak L.P., Ravi R., and Somani S.M. Mechanism of protection by diethyldithiocarbamate against cisplatin ototoxicity: antioxidant system. Fundam Appl Toxicol 26 (1995) 293-300
8. Rybak L.P., Husain K., Evenson L., et al. Protection by 4-methylthiobenzoic acid against cisplatin-induced ototoxicity: antioxidant system. Pharmacol Toxicol 81 (1997) 173-179
9. Kopke R.D., Liu W., Gabaizadeh R., et al. Use of organotypic cultures of Corti's organ to study the protective effects of antioxidant molecules on cisplatin-induced damage of auditory hair cells. Am J Otol 18 (1997) 559-571
10. Parnes L.S., Sun A.H., and Freeman D.J. Corticosteroid pharmacokinetics in the inner ear fluids: an animal study followed by clinical application. Laryngoscope 109 (1999) 1-17
11. Gorga M.P., Neely S.T., and Dorn P.A. Distortion product otoacoustic emissions in relation to hearing loss. In: Robinette R.M., and Glattke T. (Eds). Otoacoustic emissions: clinical applications. 2nd ed. (2002), Thieme, New York 243-272
12. Ress B.D., Sridhar K.S., Balkany T.J., et al. Effects of cis-platinum chemotherapy on otoacoustic emissions: the development of an objective screening protocol. Third place-Resident Clinical Science Award 1998. Otolaryngol Head Neck Surg 121 (1999) 693-701
13. Yilmaz I., Yilmazer C., Erkan A.N., et al. Intratympanic dexamethasone injection effects on transient-evoked otoacoustic emission. Am J Otolaryngol 26 (2005) 113-117
14. Takumida M., Anniko M., Popa R., et al. Pharmacological models for inner ear therapy with emphasis on nitric oxide. Acta Otolaryngol 121 (2001) 16-20
15. Chandrasekhar S.S. Intratympanic dexamethasone for sudden sensorineural hearing loss: clinical and laboratory evaluation. Otol Neurotol 22 (2001) 18-23
16. Silverstein H., Choo D., Rosenberg S.I., et al. Intratympanic steroid treatment of inner ear disease and tinnitus (preliminary report). Ear Nose Throat J 75 (1996) 468-471 474, 476
17. Himeno C., Komeda M., Izumikawa M., et al. Intra-cochlear administration of dexamethasone attenuates aminoglycoside ototoxicity in the guinea pig. Hear Res 167 (2002) 61-70
18. Tuor U.I. Glucocorticoids and the prevention of hypoxic-ischemic brain damage. Neurosci Biobehav Rev 21 2 (1997) 175-179
19. Palmer R.M., Bridge L., Foxwell N.A., et al. The role of nitric oxide in endothelial cell damage and its inhibition by glucocorticoids. Br J Pharmacol 105 (1992) 11-12
20. Silverstein H., Isaacson J.E., Olds M.J., et al. Dexamethasone inner ear perfusion for the treatment of Meniere's disease: a prospective, randomized, double-blind, crossover trial. Am J Otol 19 (1998) 196-201
21. Zhang C., Marme A., Wenger T., et al. Glucocorticoid-mediated inhibition of chemotherapy in ovarian carcinomas. Int J Oncol 28 (2006) 551-558